LOAME
BIIB icon

Lombard Odier Asset Management (Europe)’s Biogen BIIB Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,686
Closed -$1.09M – 267
2024
Q2 		$1.09M Buy
+4,686
New +$1.02M 0.05% 241
2023
Q2 		– Sell
-4,205
Closed -$1.17M – 244
2023
Q1 		$1.17M Sell
4,205
-393
-9% -$109K 0.06% 221
2022
Q4 		$1.27M Sell
4,598
-4,798
-51% -$1.36M 0.05% 230
2022
Q3 		$2.51M Sell
9,396
-2,339
-20% -$497K 0.13% 158
2022
Q2 		$2.39M Buy
+11,735
New +$2.4M 0.12% 162
2022
Q1 		– Sell
-6,685
Closed -$1.6M – 179
2021
Q4 		$1.6M Buy
+6,685
New +$1.72M 0.07% 142
2020
Q4 		– Sell
-1,654
Closed -$469K – 228
2020
Q3 		$469K Buy
+1,654
New +$461K 0.03% 191
2020
Q2 		– Sell
-1,654
Closed -$523K – 156
2020
Q1 		$523K Sell
1,654
-454
-22% -$138K 0.04% 156
2019
Q4 		$626K Hold
2,108
– – 0.05% 167
2019
Q3 		$491K Sell
2,108
-96
-4% -$22.4K 0.04% 193
2019
Q2 		$515K Hold
2,204
– – 0.04% 187
2019
Q1 		$521K Hold
2,204
– – 0.05% 166
2018
Q4 		$663K Hold
2,204
– – 0.06% 145
2018
Q3 		$779K Hold
2,204
– – 0.05% 151
2018
Q2 		$640K Buy
2,204
+120
+6% +$33.7K 0.05% 156
2018
Q1 		$571K Sell
2,084
-301
-13% -$93.4K 0.04% 172
2017
Q4 		$760K Sell
2,385
-214
-8% -$68.7K 0.05% 155
2017
Q3 		$814K Sell
2,599
-327
-11% -$96.8K 0.05% 159
2017
Q2 		$794K Hold
2,926
– – 0.05% 150
2017
Q1 		$800K Sell
2,926
-511
-15% -$144K 0.04% 134
2016
Q4 		$975K Hold
3,437
– – 0.35% 70
2016
Q3 		$1.08M Hold
3,437
– – 0.37% 69
2016
Q2 		$831K Buy
+3,437
New +$906K 0.04% 133

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s BIIB Position: Q3 2024 in Review

Lombard Odier Asset Management (Europe) sold out of Biogen (BIIB) in Q3 2024, closing a stake of 4,686 shares — an estimated $1.09M sold.

Lombard Odier Asset Management (Europe) first reported a position in BIIB in Q2 2016 and held it in 23 quarters. The position peaked at $2.51M in Q3 2022. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Lombard Odier Asset Management (Europe) reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 4,686 Biogen shares in Q3 2024, an estimated $1.09M.
  • Lombard Odier Asset Management (Europe) first reported a position in Biogen in Q2 2016 and held it in 23 quarters.
  • Lombard Odier Asset Management (Europe)'s Biogen position peaked at $2.51M in Q3 2022.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q3 2024, filed 14 Nov 2024.